HeiQ Viroblock certified as cosmetic grade & bio-based renewable

Leading the international textile industry to fight the COVID-19 pandemic, HeiQ recently launched HeiQ Viroblock NPJ03, an antiviral and antibacterial textile treatment proven to reduce 99.99% of  human coronavirus SARS-CoV-2, the virus that causes COVID-19, along with other enveloped viruses and bacteria. Viruses and bacteria can remain infective on textile surfaces for days. Human Coronavirus Read more about HeiQ Viroblock certified as cosmetic grade & bio-based renewable[…]

The first semi-finished part made of Ultramid® Advanced N

BASF has now developed Ultramid® Advanced N5H UN, a polyphthalamide (PPA) that can be manufactured into semi-finished parts by extrusion. The plastics company GEHR, Mannheim, Germany is using the new PPA to produce extruded stock shapes with a diameter of 50 millimeters. Ultramid® Advanced N offers excellent mechanics at elevated temperatures due to its semi-aromatic Read more about The first semi-finished part made of Ultramid® Advanced N[…]

VITROCELL® TEM Grid holders for dose determination of airborne particles during in vitro Exposure at the air / liquid interface

. Background The assessment of toxicological effects of airborne particles to the human organism is of major importance in disease research. The presence of nano and ultrafine particles can be found both in indoor and outdoor atmospheres which include workplaces and living areas. Over the last years, the degree of contribution to diseases of such Read more about VITROCELL® TEM Grid holders for dose determination of airborne particles during in vitro Exposure at the air / liquid interface[…]

HeiQ and Intexso biochem celebrate seven years of partnership in the fast-growing and innovative market of India

HeiQ is a leader in textile innovation, creating some of the most effective, durable and high-performance textile effects in the market today. They have a variety of technology categories, including the recently launched HeiQ Viroblock that is tested effective against SARS-CoV-2 (COVID-19). HeiQ is an innovation partner with its distributors, and as they continue to Read more about HeiQ and Intexso biochem celebrate seven years of partnership in the fast-growing and innovative market of India[…]

Artistic Denim Mills and HeiQ collaborate to launch “Safe To Touch” denim and face mask collection

Artistic Denim Mills (ADM) is a vertical denim mill based in Karachi, Pakistan, that produces fabrics, garments and face masks for the global market. Their heritage is in jeans that give feel, fit and comfort to customers using innovative fibers and stretch technologies. Since the COVID-19 pandemic, ADM has ventured into the production of face Read more about Artistic Denim Mills and HeiQ collaborate to launch “Safe To Touch” denim and face mask collection[…]

Immunic, Inc. to Join Russell 3000® Index

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that the company is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according Read more about Immunic, Inc. to Join Russell 3000® Index[…]

The Floating Laboratory

Innovations are extremely important for the further development of the yacht industry. But how do manufacturers know in advance which ideas will prove effective or which products will actually add value compared to conventional processes? With the AZ project, a 30-metre yacht hull, International Maritime Research GmbH & Co. KG (IMR) is for the first Read more about The Floating Laboratory[…]

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced dosing of the first patients in its phase 2, CALVID-1 clinical trial of IMU-838, the company’s selective oral DHODH inhibitor, in coronavirus disease 2019 (COVID-19), at several sites in different Read more about Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19[…]

Life sciences open their doors for engineers

The European Molecular Biology Laboratory has secured 6.8 million Euros funding from the European Commission to launch a unique training programme. The ARISE Programme will train and develop Europe’s next generation leadership for research infrastructures in the life sciences. Research infrastructures are increasingly important to research and development activity by providing access to the latest Read more about Life sciences open their doors for engineers[…]

New insights into epigenetic modifications

Scientists at EMBL Rome unveil the mechanism behind the most studied epigenetic modification. The press release including visuals can be found here: https://www.embl.org/news/science/new-insights-into-epigenetic-modifications/  ‘DNA makes RNA makes protein’ is a fundamental principle in molecular biology. The process of gene expression, namely creating RNA from a specific DNA sequence, is tightly regulated in different ways. The DNA Read more about New insights into epigenetic modifications[…]